UNSPSC 51352430: Estrone/progesterone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class HS900. This VA Drug Class (HS900) classifies this compound as belonging to the group HORMONES/SYNTHETICS/MODIFIERS, OTHER.

UNSPSC 51352430 Estrone/progesterone, a Commodity code, covers pharmaceutical products — specifically estrone and progesterone formulations — that state and local health agencies, state employee health plans, and cooperative purchasing alliances source for distribution through pharmacy networks and direct-to-pharmacy programs. State and local buyers under this code include health and human services departments, multistate cooperative purchasing organizations, and entities administering state employee and retiree pharmacy benefit programs. The work involves sourcing branded and generic estrone and progesterone products through established pharmaceutical wholesalers or direct manufacturer relationships, with vendors required to meet FDA compliance, cGMP and Drug Supply Chain Security Act certification, and pricing requirements negotiated through net pricing, WAC-minus, or fixed-fee models.

The code shows recent activity centered in the Upper Midwest and Southwest. The Texas Health and Human Services Commission issued a Request for Information (RFI) in March 2026 to explore direct-to-manufacturer prescription programs that would establish relationships outside traditional pharmacy benefit manager and wholesaler channels, signaling potential future demand for manufacturers or direct-contracting vendors. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued a Request for Proposal in January 2026 with a March 26, 2026 response deadline for generic multi-source pharmaceuticals and OTC products to be distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson. MMCAP's RFP emphasizes price competitiveness (75 percent evaluation weight), maintenance of relationships with at least two authorized wholesalers with chargeback systems, and compliance with comprehensive insurance and inventory requirements. Contract awards under MMCAP span a two-year initial term with optional extensions, effective July 1, 2026 for new vendors, with no specific budget disclosed.